TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Revenue

Annual figures by fiscal year, from SEC filings.

2011: $16.81M2012: $14.11M2013: $15.46M2014: $14.95M2015: $23.28M2016: $1.49M2017: $10.70M2018: $5.95M2019: $6.01M2020: $6.91M2021: $10.99M2022: $39.02M2023: $18.14M2024: $6.17M2025: $14.08M$14.08M
2011Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$14.08M+128.2%
2024$6.17M-66.0%
2023$18.14M-53.5%
2022$39.02M+255.1%
2021$10.99M+58.9%
2020$6.91M+15.0%
2019$6.01M+1.1%
2018$5.95M-44.4%
2017$10.70M+617.6%
2016$1.49M-93.6%
2015$23.28M+55.7%
2014$14.95M-3.3%
2013$15.46M+9.6%
2012$14.11M-16.1%
2011$16.81M—